Literature DB >> 29530886

Hyperacute Monocyte Gene Response Patterns Are Associated With Lower Extremity Vein Bypass Graft Failure.

Jonathan P Rehfuss1, Kenneth M DeSart1, Jared M Rozowsky1, Kerri A O'Malley1, Lyle L Moldawer1, Henry V Baker1, Yaqun Wang1, Rongling Wu1, Peter R Nelson1, Scott A Berceli2.   

Abstract

BACKGROUND: Despite being the definitive treatment for lower extremity peripheral arterial disease, vein bypass grafts fail in half of all cases. Early repair mechanisms after implantation, governed largely by the immune environment, contribute significantly to long-term outcomes. The current study investigates the early response patterns of circulating monocytes as a determinant of graft outcome.
METHODS: In 48 patients undergoing infrainguinal vein bypass grafting, the transcriptomes of circulating monocytes were analyzed preoperatively and at 1, 7, and 28 days post-operation.
RESULTS: Dynamic clustering algorithms identified 50 independent gene response patterns. Three clusters (64 genes) were differentially expressed, with a hyperacute response pattern defining those patients with failed versus patent grafts 12 months post-operation. A second independent data set, comprised of 96 patients subjected to major trauma, confirmed the value of these 64 genes in predicting an uncomplicated versus complicated recovery. Causal network analysis identified 8 upstream elements that regulate these mediator genes, and Bayesian analysis with a priori knowledge of the biological interactions was integrated to create a functional network describing the relationships among the regulatory elements and downstream mediator genes. Linear models predicted the removal of either STAT3 (signal transducer and activator of transcription 3) or MYD88 (myeloid differentiation primary response 88) to shift mediator gene expression levels toward those seen in successful grafts.
CONCLUSIONS: A novel combination of dynamic gene clustering, linear models, and Bayesian network analysis has identified a core set of regulatory genes whose manipulations could migrate vein grafts toward a more favorable remodeling phenotype.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  computational biology; genomics; humans; monocytes; peripheral vascular diseases

Mesh:

Substances:

Year:  2018        PMID: 29530886      PMCID: PMC5854207          DOI: 10.1161/CIRCGEN.117.001970

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  45 in total

Review 1.  The role of microRNAs in arterial remodelling.

Authors:  M Nazari-Jahantigh; Y Wei; A Schober
Journal:  Thromb Haemost       Date:  2012-02-28       Impact factor: 5.249

Review 2.  Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries.

Authors:  J L Cox; D A Chiasson; A I Gotlieb
Journal:  Prog Cardiovasc Dis       Date:  1991 Jul-Aug       Impact factor: 8.194

3.  US Renal Data System 2010 Annual Data Report.

Authors:  Allan J Collins; Robert N Foley; Charles Herzog; Blanche Chavers; David Gilbertson; Areef Ishani; Bertram Kasiske; Jiannong Liu; Lih-Wen Mau; Marshall McBean; Anne Murray; Wendy St Peter; Haifeng Guo; Sally Gustafson; Qi Li; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

4.  Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

Authors:  S Goldman; J Copeland; T Moritz; W Henderson; K Zadina; T Ovitt; J Doherty; R Read; E Chesler; Y Sako
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

5.  Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.

Authors:  Sonya B Sonnenberg; Aboli A Rane; Cassie J Liu; Nikhil Rao; Gillie Agmon; Sophia Suarez; Raymond Wang; Adam Munoz; Vaibhav Bajaj; Shirley Zhang; Rebecca Braden; Pamela J Schup-Magoffin; Oi Ling Kwan; Anthony N DeMaria; Jennifer R Cochran; Karen L Christman
Journal:  Biomaterials       Date:  2015-01-13       Impact factor: 12.479

6.  Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.

Authors:  Richard D Kenagy; Mete Civelek; Shinsuke Kikuchi; Lihua Chen; Anthony Grieff; Michael Sobel; Aldons J Lusis; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2015-04-30       Impact factor: 4.268

7.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Authors:  L Campeau; M Enjalbert; J Lespérance; M G Bourassa; P Kwiterovich; S Wacholder; A Sniderman
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

8.  Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients.

Authors:  Alex G Cuenca; Lori F Gentile; M Cecilia Lopez; Ricardo Ungaro; Huazhi Liu; Wenzhong Xiao; Junhee Seok; Michael N Mindrinos; Darwin Ang; Tezcan Ozrazgat Baslanti; Azra Bihorac; Philip A Efron; Joseph Cuschieri; H Shaw Warren; Ronald G Tompkins; Ronald V Maier; Henry V Baker; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

9.  Cross talk between vascular smooth muscle cells and monocytes through interleukin-1β/interleukin-18 signaling promotes vein graft thickening.

Authors:  Ping Li; Yu-lin Li; Zhen-ya Li; Yi-na Wu; Cong-cong Zhang; Xi A; Chun-xiao Wang; Hong-tao Shi; Mi-zhou Hui; Bo Xie; Mohammed Ahmed; Jie Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-10       Impact factor: 8.311

10.  Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease.

Authors:  Zhi-Jian Yang; You-Rong Zhang; Bo Chen; Shu-Lan Zhang; En-Zhi Jia; Lian-Sheng Wang; Tie-Bing Zhu; Chun-Jian Li; Hui Wang; Jun Huang; Ke-Jiang Cao; Wen-Zhu Ma; Bin Wu; Li-Sheng Wang; Chu-Tse Wu
Journal:  Mol Biol Rep       Date:  2008-07-22       Impact factor: 2.316

View more
  2 in total

1.  An omnidirectional visualization model of personalized gene regulatory networks.

Authors:  Chixiang Chen; Libo Jiang; Guifang Fu; Ming Wang; Yaqun Wang; Biyi Shen; Zhenqiu Liu; Zuoheng Wang; Wei Hou; Scott A Berceli; Rongling Wu
Journal:  NPJ Syst Biol Appl       Date:  2019-10-11

Review 2.  The Role of Immunomodulation in Vein Graft Remodeling and Failure.

Authors:  Fabiana Baganha; Alwin de Jong; J Wouter Jukema; Paul H A Quax; Margreet R de Vries
Journal:  J Cardiovasc Transl Res       Date:  2020-06-16       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.